Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07164131 · ClinicalTrials.gov registry record · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
A Phase 4 study of Community-acquired Pneumonia, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 1,120
- Enrollment target
- 5
- Study locations
NCT07164131 is a Phase 4 study of Community-acquired Pneumonia that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,120 participants, below the 108,997-participant average among 9 other Community-acquired Pneumonia trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT07164131, a Phase 4 study of Community-acquired Pneumonia, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 1,120 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP) treated with Beta-lactams.
Conditions Studied
Interventions
- DRUG Azithromycin
- DRUG Doxycycline
Study Locations (5)
Minnesota
- Mayo Clinic Health System-Mankato - Mankato
- Mayo Clinic in Rochester - Rochester
Arizona
- Mayo Clinic in Arizona - Scottsdale
Florida
- Mayo Clinic in Florida - Jacksonville
Wisconsin
- Mayo Clinic Health System-La Crosse - La Crosse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,120 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2031-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07164131
The ClinicalTrials.gov registry entry for NCT07164131 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 1,120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 108,997-participant average among 9 other Community-acquired Pneumonia trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Community-acquired Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which Azithromycin is the first listed.
NCT07164131 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Minnesota, Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT07164131 about?
NCT07164131 is a clinical study titled "Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams". The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP) treated with Beta-lactams.
What is the current status of trial NCT07164131?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 1,120 participants. The study started on 2025-09-15. Estimated completion is 2031-09-01.
What conditions does trial NCT07164131 study?
This clinical trial studies the following conditions: Community-acquired Pneumonia.
What interventions are being tested in trial NCT07164131?
The interventions under investigation include: Azithromycin (DRUG), Doxycycline (DRUG).
Who is sponsoring clinical trial NCT07164131?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07164131 being conducted?
This trial has 5 study locations across Arizona, Florida, Minnesota, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Community-acquired Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia
RECRUITING · NA
-
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
RECRUITING · Phase 3
-
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
RECRUITING · Phase 3
-
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
RECRUITING
-
Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
RECRUITING · NA
-
Discharge Stewardship in Children's Hospitals
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.